TriplePoint Venture Growth BDC Corp.
TPVG NYSE Financials FY2020βFY2025
What TriplePoint Venture Growth BDC Corp. does
No business description yet.
- Legal name
- TriplePoint Venture Growth BDC Corp.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 4, 2026
- Accession Β· CIK
- 0001580345-26-000008
0001580345
Revenue and margins
TriplePoint Venture Growth BDC Corp. had $2.1M of revenue in fiscal 2025, up 14.9% on the year before.
Net income and earnings per share
From fiscal 2020 to 2025, diluted EPS grew β7.7% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
TriplePoint Venture Growth BDC Corp. returned β to shareholders in fiscal 2025. The diluted share count rose 3.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably TriplePoint Venture Growth BDC Corp. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $51.3M | $51.5M | $153M | $45.9M | $20.4M |
| Debt incl. finance leases | $465M | $563M | $605M | $395M | $464M |
| Debt / equity | 1.1x | 1.3x | 1.7x | 1.1x | 1.3x |
| Total assets | $928M | $1.0B | $979M | $763M | $840M |
| Total liabilities | $493M | $595M | $633M | $417M | $486M |
| Shareholders' equity | $434M | $420M | $346M | $346M | $354M |
| Net debt (β = net cash) | $414M | $511M | $452M | $349M | $444M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β |
| F-score | β / 1 | β / 4 | 0 / 7 | 2 / 7 | 5 / 7 | 3 / 7 |
| Accruals ratio | β | 23.8% | 8.3% | β14.6% | β13.9% | 13.3% |
| Altman Z'' | β | β | β | β | β | β |
6 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | $1.2M | $3.6M | $2.7M | $2.3M | $1.8M | $2.1M |
| Noninterest income | $1.2M | $3.6M | $2.7M | $2.3M | $1.8M | $2.1M |
| Interest expense | $15.5M | $17.4M | $26.8M | $36.8M | β | β |
| Net income | β | $76.6M | β$20.1M | β$39.8M | $32.0M | $49.2M |
| Diluted EPS | $1.57 | $1.33 | $1.94 | $2.07 | $1.40 | $1.05 |
| Diluted shares | 0.03B | 0.03B | 0.03B | 0.04B | 0.04B | 0.04B |
| Cash flow | ||||||
| Cash from operations | $63.7M | β$145M | β$101M | $106M | $153M | β$57.0M |
| Balance sheet | ||||||
| Cash and short-term investments | $38.2M | $51.3M | $51.5M | $153M | $45.9M | $20.4M |
| Total debt | β | $465M | $563M | $605M | $395M | $464M |
| Total assets | β | $928M | $1.0B | $979M | $763M | $840M |
| Total liabilities | β | $493M | $595M | $633M | $417M | $486M |
| Preferred stock | β | β | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $400M | $434M | $420M | $346M | $346M | $354M |
| Margins | ||||||
| Net margin | β | 2,131.9% | β745.8% | β1,697.4% | 1,755.9% | 2,346.5% |
| Returns | ||||||
| Return on equity | β | 18.3% | β4.7% | β10.4% | 9.3% | 14.1% |
| Return on assets | β | 8.3% | β2.1% | β4.0% | 3.7% | 6.1% |
| Return on tangible equity | β | 17.6% | β4.8% | β11.5% | 9.3% | 13.9% |
| Growth | ||||||
| Revenue growth | β | 197.3% | β25.1% | β12.8% | β22.2% | 14.9% |
| Net income growth | β | β | β126.2% | β | β | 53.6% |
| EPS growth | β | β15.3% | 45.9% | 6.7% | β32.4% | β25.0% |
| Share count change | β | 1.2% | 5.7% | 9.2% | 9.5% | 3.0% |
| Financial health | ||||||
| Debt / equity | β | 1.1x | 1.3x | 1.7x | 1.1x | 1.3x |
| Quality scores | ||||||
| Piotroski F-score | β | β | 0.0 | 2.0 | 5.0 | 3.0 |
| Accruals ratio | β | 23.8% | 8.3% | β14.6% | β13.9% | 13.3% |
Source: SEC EDGAR XBRL filings (CIK 0001580345). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.